ArticleFrontiers in oncology2021

Atractylenolide-I Sensitizes Triple-Negative Breast Cancer Cells to Paclitaxel by Blocking CTGF Expression and Fibroblast Activation.

Meng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.